In a patient with portal hypertension, elevations in vascular endothelial growth factor (VEGF), which is released by dysfunctional hepatic sinusoidal endothelial cells, HSCs and hepatocytes in response to inflammation [43], lead to the formation of collateral blood vessels that bypass the portal vein and decompress the portal system. This evidence concerns the gene VEGFA and liver disorder.